Clinicopathologic Significance of Cyclin A Expression in Colorectal Carcinoma

Journal of Experimental and Clinical Cancer Research

Volumn 23, Issue 1, 2004, Pages 127-133

  Nozoe, Tadahiro ^a,b   Inutsuka, S ^a   Honda, M ^a   Ezaki, T ^b   Korenaga, D ^a  

^a FUKUOKA DENTAL COLLEGE   (Japan)

^b FUKUOKA HIGASHI MEDICAL CENTER   (Japan)

Author keywords

Colorectal carcinoma; Cyclin A; Immunohistochemistry; Prognostic indicator

Indexed keywords

CYCLIN A;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MITOSIS; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CELL DIFFERENTIATION; COLORECTAL NEOPLASMS; CYCLIN A; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; TIME FACTORS;

EID: 2142761088     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Pines J., Hunter T.: Isolation of a cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2. Cell 58:833-846, 1989.
2. Sherr C.J.: Cancer cell cycles. Science 274:1672-1677, 1996.
3. Hunter T., Pines J.: Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age. Cell 79:573-582, 1994.
4. Cordon-Cardo C.: Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia. Am. J. Pathol. 147:545-560, 1995.
5. Hunter T., Pines J.: Cyclins and cancer. A review. Cell 66:1071-1074, 1991.
6. Pagano M., Pepperkok R., Verde F., Ansorge W., Draetta G.: Cyclin A is required at two points in the human cell cycle. EMBO. J. 11:961-971, 1992.
7. Xiong Y., Connolly T., Futcher B., Beach D.: Human D-type cyclin. Cell 65:691-699, 1991.
8. Wang J., Zindy F., Chenivesse X., Lamas E., Henglein B., Brechot C.: Modification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma. Oncogene 7:1653-1656, 1992.
9. Pines J., Hunter T.: Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B. Nature 346:760-763, 1990.
10. Faha B., Ewen M.E., Tsai L.H., Livingston D.M., Harlow E.: Interaction between human cyclin A and adenovirus E1A-associated p107. Science 255:87-90, 1992.
11. Girard F., Strausfeld U., Fernandez A., Lamb N.J.: Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 67:1169-1179, 1991.
12. Allan K., Jordan R.C., Ang L.C., Taylor M., Young B.: Overexpression of cyclin A and cyclin B1 proteins in astrocytomas. Arch. Pathol. Lab. Med. 124:216-220, 2000.
13. Florenes V.A., Malandsmo G.M., Faye R., Nesland J.M., Holm R.: Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome. J. Pathol. 195:530-536, 2001.
14. Bukholm I.R., Bukholm G., Nesland J.M.: Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas. Int. J. Cancer 93:283-287, 2001.
15. (waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patients survival. Br. J. Cancer 80:2001-2007, 1999.
16. Volm M., Koomägi R., Mattern J., Stammler G.: Cyclin A is associated with an unfavourable outcome in patients with non-small-cell carcinoma. Br. J. Cancer 75:1774-1778, 1997.
17. Furihata M., Ohtsuki Y., Sonobe H., et al.: Cyclin A overexpression in carcinoma of the renal pelvis and ureter including dysplasia: immunohistochemical findings in relation to prognosis. Clin. Cancer Res. 3:1399-1404, 1997.
18. Furihata M., Ishikawa T., Inoue A., et al.: Determination of the prognostic significance of unscheduled cyclin A overexpression in patients with esophageal squamous cell carcinoma. Clin. Cancer Res. 2:1781-1785, 1996.
19. Japanese Research Society for Cancer of the Colon and Rectum: Japanese Classification of Colorectal Carcinoma, The 1st, Kanehara & Co., Ltd, Tokyo, 1997.
20. Handa K., Yamakawa M., Takeda H., Kimura S., Takahashi T.: Expression of cell cycle markers in colorectal carcinoma:superiority of cyclin A as an indicator of poor prognosis. Int. J. Cancer 84:225-233, 1999.
21. Kammerer U., Kapp M., Gassel A.M., et al.: A new rapid immunohistochemical staining technique using the EnVision antibody complex. J. Histochem. Cytochem. 49:623-630, 2001.
22. Sabattini E., Bisgaard K., Ascani S., et al.: The EnVision++ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, Chem-Mate, CSA, LABC, and SABC techniques. J. Clin. Pathol. 51:506-511, 1998.
23. Dukes C.E., Bussey H.J.R.: The spread of rectal cancer and its effect on prognosis. Br. J. Cancer 12:309-320, 1958.
24. Li J.Q., Miki H., Wu F., et al.: Cyclin A correlates with carcinogenesis and metastasis, and p27 (kip1) correlates with lymphatic invasion, in colorectal neoplasms. Hum. Pathol. 33:1006-1015, 2002.
25. Wang A., Yoshimi N., Suzui M., Yamaguchi A., Tarao M., Mori H.: Different expression patterns of cyclin A, D1 and E in human colorectal cancer. J. Cancer Res. Clin. Oncol. 122:122-126, 1996.
26. Yasui W., Kuniyasu H., Yokozaki H., Semba S., Shimamoto F., Tahara E.: Expression of cyclin E in colorectal adenomas and adenocarcinomas: correlation with expression of Ki-67 antigen and p53 protein. Virchows. Arch. 429:13-19, 1996.
27. Maeda K., Chung Y.S., Kang S.M., et al.: Overexpression of cyclin D1 and p53 associated with disease recurrence in colorectal adenocarcinoma. Int. J. Cancer 74:310-315, 1997.
28. Wang A., Yoshimi N., Ino N., Tanaka T., Mori H.: Overexpression of cyclin B1 in human colorectal cancers. J. Cancer Res. Clin. Oncol. 123:124-127, 1997.
29. Maeda K., Chung Y., Kang S., et al.: Cyclin D1 over-expression and prognosis in colorectal adenocarcinoma. Oncology 55:145-151, 1998.
30. Palmqvist R., Stenling R., Oberg A., Landberg G.: Expression of cyclin D1 and retinoblastoma protein in colorectal cancer. Eur. J. Cancer 34:1575-1581, 1998.
31. McKay J.A., Douglas J.J., Ross V.G., et al.: Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases. Clin. Cancer Res. 6:1113-1118, 2000.
32. Bhatavdekar J.M., Patel D.D., Chikhlikar P.R., et al.: Molecular markers are predictors of recurrence and survival in patients with Dukes B and Dukes C colorectal adenocarcinoma. Dis. Colon. Rectum 44:523-533, 2001.
33. Li J.Q., Miki H., Ohmori M., Wu F., Funamoto Y.: Expression of cyclin E and cyclin-dependent kinase 2 correlates with metastasis and prognosis in colorectal carcinoma. Hum. Pathol. 32:945-953, 2001.
34. (WAF1/CIP1) expression and correlates with patient survival. Int. J. Cancer 95:302-306, 2001.
35. Chung C.K., Zaino R.J., Stryker J.A.: Colorectal carcinoma: evaluation of histologic grade and factors influencing prognosis. J. Surg. Oncol. 21:143-148, 1982.
36. Nozoe T., Anai H., Nasn S., Sugimachi K.: Clinicopathological characteristics of mucinous carcinoma of the colon and rectum. J. Surg. Oncol. 75:103-107, 2000.